The fda wanted additional data. They now have that additional.
Nothing stopping the FDA from saying Remestemcel-L APPROVED
treatment for sr-aGVHD.
The fda wanted additional data. They now have that additional....
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.010(0.91%) |
Mkt cap ! $1.230B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $3.515M | 3.240M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 22111 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 53749 | 15 |
View Market Depth
| Last trade - 13.41pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |